Cargando…

Erratum to: First-in-human phase I study of SOR-C13, a TRPV6 calcium channel inhibitor, in patients with advanced solid tumors

Detalles Bibliográficos
Autores principales: Fu, S., Hirte, H., Welch, S., Ilenchuk, T. T., Lutes, T., Rice, C., Fields, N., Nemet, A., Dugourd, D., Piha-Paul, S., Subbiah, V., Liu, L., Gong, J., Hong, D., Stewart, J. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443850/
https://www.ncbi.nlm.nih.gov/pubmed/28389981
http://dx.doi.org/10.1007/s10637-017-0455-y
_version_ 1783238634071130112
author Fu, S.
Hirte, H.
Welch, S.
Ilenchuk, T. T.
Lutes, T.
Rice, C.
Fields, N.
Nemet, A.
Dugourd, D.
Piha-Paul, S.
Subbiah, V.
Liu, L.
Gong, J.
Hong, D.
Stewart, J. M.
author_facet Fu, S.
Hirte, H.
Welch, S.
Ilenchuk, T. T.
Lutes, T.
Rice, C.
Fields, N.
Nemet, A.
Dugourd, D.
Piha-Paul, S.
Subbiah, V.
Liu, L.
Gong, J.
Hong, D.
Stewart, J. M.
author_sort Fu, S.
collection PubMed
description
format Online
Article
Text
id pubmed-5443850
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-54438502017-06-09 Erratum to: First-in-human phase I study of SOR-C13, a TRPV6 calcium channel inhibitor, in patients with advanced solid tumors Fu, S. Hirte, H. Welch, S. Ilenchuk, T. T. Lutes, T. Rice, C. Fields, N. Nemet, A. Dugourd, D. Piha-Paul, S. Subbiah, V. Liu, L. Gong, J. Hong, D. Stewart, J. M. Invest New Drugs Erratum Springer US 2017-04-07 2017 /pmc/articles/PMC5443850/ /pubmed/28389981 http://dx.doi.org/10.1007/s10637-017-0455-y Text en © Springer Science+Business Media New York 2017
spellingShingle Erratum
Fu, S.
Hirte, H.
Welch, S.
Ilenchuk, T. T.
Lutes, T.
Rice, C.
Fields, N.
Nemet, A.
Dugourd, D.
Piha-Paul, S.
Subbiah, V.
Liu, L.
Gong, J.
Hong, D.
Stewart, J. M.
Erratum to: First-in-human phase I study of SOR-C13, a TRPV6 calcium channel inhibitor, in patients with advanced solid tumors
title Erratum to: First-in-human phase I study of SOR-C13, a TRPV6 calcium channel inhibitor, in patients with advanced solid tumors
title_full Erratum to: First-in-human phase I study of SOR-C13, a TRPV6 calcium channel inhibitor, in patients with advanced solid tumors
title_fullStr Erratum to: First-in-human phase I study of SOR-C13, a TRPV6 calcium channel inhibitor, in patients with advanced solid tumors
title_full_unstemmed Erratum to: First-in-human phase I study of SOR-C13, a TRPV6 calcium channel inhibitor, in patients with advanced solid tumors
title_short Erratum to: First-in-human phase I study of SOR-C13, a TRPV6 calcium channel inhibitor, in patients with advanced solid tumors
title_sort erratum to: first-in-human phase i study of sor-c13, a trpv6 calcium channel inhibitor, in patients with advanced solid tumors
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443850/
https://www.ncbi.nlm.nih.gov/pubmed/28389981
http://dx.doi.org/10.1007/s10637-017-0455-y
work_keys_str_mv AT fus erratumtofirstinhumanphaseistudyofsorc13atrpv6calciumchannelinhibitorinpatientswithadvancedsolidtumors
AT hirteh erratumtofirstinhumanphaseistudyofsorc13atrpv6calciumchannelinhibitorinpatientswithadvancedsolidtumors
AT welchs erratumtofirstinhumanphaseistudyofsorc13atrpv6calciumchannelinhibitorinpatientswithadvancedsolidtumors
AT ilenchuktt erratumtofirstinhumanphaseistudyofsorc13atrpv6calciumchannelinhibitorinpatientswithadvancedsolidtumors
AT lutest erratumtofirstinhumanphaseistudyofsorc13atrpv6calciumchannelinhibitorinpatientswithadvancedsolidtumors
AT ricec erratumtofirstinhumanphaseistudyofsorc13atrpv6calciumchannelinhibitorinpatientswithadvancedsolidtumors
AT fieldsn erratumtofirstinhumanphaseistudyofsorc13atrpv6calciumchannelinhibitorinpatientswithadvancedsolidtumors
AT nemeta erratumtofirstinhumanphaseistudyofsorc13atrpv6calciumchannelinhibitorinpatientswithadvancedsolidtumors
AT dugourdd erratumtofirstinhumanphaseistudyofsorc13atrpv6calciumchannelinhibitorinpatientswithadvancedsolidtumors
AT pihapauls erratumtofirstinhumanphaseistudyofsorc13atrpv6calciumchannelinhibitorinpatientswithadvancedsolidtumors
AT subbiahv erratumtofirstinhumanphaseistudyofsorc13atrpv6calciumchannelinhibitorinpatientswithadvancedsolidtumors
AT liul erratumtofirstinhumanphaseistudyofsorc13atrpv6calciumchannelinhibitorinpatientswithadvancedsolidtumors
AT gongj erratumtofirstinhumanphaseistudyofsorc13atrpv6calciumchannelinhibitorinpatientswithadvancedsolidtumors
AT hongd erratumtofirstinhumanphaseistudyofsorc13atrpv6calciumchannelinhibitorinpatientswithadvancedsolidtumors
AT stewartjm erratumtofirstinhumanphaseistudyofsorc13atrpv6calciumchannelinhibitorinpatientswithadvancedsolidtumors